Robichaux, Jacqulyne P.
Elamin, Yasir Y.
Tan, Zhi
Carter, Brett W.
Zhang, Shuxing
Liu, Shengwu
Li, Shuai
Chen, Ting
Poteete, Alissa
Estrada-Bernal, Adriana
Le, Anh T.
Truini, Anna
Nilsson, Monique B.
Sun, Huiying
Roarty, Emily
Goldberg, Sarah B.
Brahmer, Julie R.
Altan, Mehmet
Lu, Charles
Papadimitrakopoulou, Vassiliki
Politi, Katerina
Doebele, Robert C.
Wong, Kwok-Kin
Heymach, John V.
Article History
Received: 29 June 2017
Accepted: 7 February 2018
First Online: 23 April 2018
Competing interests
: J.P.R., M.B.N., and J.V.H. have filed patent applications under the Patent Cooperation Treaty and in Taiwan. J.V.H. has had grant or research support from AstraZeneca, Bayer, and GlaxoSmithKline and has served on advisory committees for AstraZeneca, Boehringer Ingelheim, Exelixis, Genentech, GSK, Lilly, Novartis, Spectrum, and Synta. R.C.D. has licensing fees, honorarium, and travel expenses from Ariad Pharmaceuticals, has a Sponsored Research Agreement from Threshold Pharmaceuticals, and has served as an advisory Board member for AstraZeneca.